Home/Products/VOGLIRITE-GM3 TABS
VOGLIRITE-GM3 TABS
— Product

VOGLIRITE-GM3 TABS

GLIMEPIRIDE 2MG + METFORMINE 500MG + VOGLIBOSE 0.3MG

VOGLIRITE-GM3 TABS is a tablet combining glimepiride 2 mg, metformin 500 mg and voglibose 0.3 mg, a triple oral combination for type 2 diabetes mellitus. It is used where dual therapy has failed to control glycaemia, adding an alpha-glucosidase inhibitor that specifically targets post-meal glucose rises.

Enquire about this product → Back to catalog
01

Benefits

  • Three complementary mechanisms — reduced hepatic glucose output, stimulated insulin secretion, and delayed intestinal carbohydrate absorption.
  • Voglibose delays the breakdown of dietary carbohydrate, blunting the post-meal glucose spike that other agents address less well.
  • Post-meal glucose control is particularly relevant to the carbohydrate-heavy diets common in India.
  • Voglibose is weight-neutral and does not itself cause hypoglycaemia.
  • A single tablet replaces three, which matters substantially for adherence.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Flatulence, bloating and abdominal distension from the voglibose
  • Diarrhoea or abdominal discomfort
  • Hypoglycaemia — sweating, tremor, hunger, palpitations, confusion
  • Nausea
Less common
  • Weight gain from the glimepiride
  • Metallic taste
  • Raised liver enzymes
  • Vitamin B12 deficiency with long-term metformin use
Stop and get medical help if any of these occur
  • Severe hypoglycaemia with confusion, seizures or loss of consciousness
  • Deep rapid breathing, severe weakness, muscle pain and vomiting — this may be lactic acidosis
  • Severe abdominal distension with vomiting and absent bowel movements
  • Yellowing of the skin or eyes
  • Widespread rash with blistering or peeling skin
03

Precautions

  • If hypoglycaemia occurs on this combination it must be treated with GLUCOSE, not ordinary sugar or sweets. Voglibose blocks the breakdown of sucrose, so table sugar will not raise blood glucose quickly. Every patient must be told this and should carry glucose tablets.
  • Glimepiride causes hypoglycaemia, which can be severe and prolonged, particularly in the elderly and with missed meals.
  • Metformin can cause lactic acidosis — stop during acute illness with dehydration, before contrast procedures and before major surgery.
  • Voglibose flatulence and bloating are common and are the main reason patients stop; they usually settle over a few weeks.
  • Contraindicated in type 1 diabetes, diabetic ketoacidosis, significant renal impairment, severe hepatic impairment, and in inflammatory bowel disease or intestinal obstruction.
  • Take immediately before meals — voglibose has no effect if taken away from food.
  • Beta-blockers mask the warning signs of hypoglycaemia.
  • Contraindicated in pregnancy and breastfeeding; check vitamin B12 periodically.